Inception Fertility™ Announces the Acceptance of 36 Abstracts to be Presented at the 2024 ASRM Scientific Congress

News provided by

Oct 21, 2024, 09:00 ET

Physicians and scientists from Inception's global network of clinics, The Prelude Network®, will present groundbreaking findings in reproductive medicine at the industry's most prestigious scientific gathering of multidisciplinary experts.

HOUSTON, Oct. 21, 2024 /PRNewswire/ -- Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, announces today 36 abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2024 ASRM Scientific Congress, on October 19-23, 2024, in Denver, Colorado.

ASRM is a professional organization dedicated to the advancement of the science and practice of reproductive medicine. This year's annual Scientific Congress will feature pioneering new technologies to progressive and inclusive approaches in patient care. The multi-disciplinary professionals who attend this event will share the latest scientific breakthroughs and discoveries in reproductive endocrinology and infertility.

"The researchers and physicians within Prelude's esteemed network of clinics continue to show their dedication to advancing reproductive medicine through insightful and meaningful research," says TJ Farnsworth, Founder and CEO of Inception Fertility, the parent company to Prelude. "We look forward to another remarkable year at the ASRM Scientific Congress and continuing the growth in the field of fertility."

Physicians and scientists from across Prelude's global network will present abstracts on some of the most pressing topics in reproductive medicine, including expanding preimplantation genetic testing, artificial intelligence and fertility, expectations and discrepancies in patient-centered care, and others. NYU Langone Fertility Center will have 23 abstracts presented at this year's ASRM conference. Additionally, an abstract about the long-term follow-up of oocyte donors presented on Monday, is an ASRM Scientific Congress Prize Paper, an award given to the best oral presentations at the ASRM Scientific Congress.

"Evident in the exceptional amount of research submitted to the 2024 ASRM Scientific Congress, Prelude is committed to being at the forefront of advancing reproductive medicine," says Dr. Jamie Grifo, Program Director at NYU Langone Fertility Center, Chief Executive Physician at Inception Fertility. "I am fortunate to work alongside incredible physicians, scientists, and embryologists who are dedicated to the improvement of patient care and the future of our field of medicine."

"Without a doubt, the best way to improve patient care is through science," says Dr. Alice Domar, Chief Compassion Officer, Inception Fertility, Director of the Inception Research Institute. "Our diverse range of research that will be presented at this year's ASRM Scientific Congress highlights innovative treatments that will improve the field of fertility, from the science of treatment to the emotional well-being of infertility patients."

To see a complete list of those Prelude abstracts that will be presented at the 2024 ASRM Scientific Congress, please visit https://inceptionfertility.com/inception-fertility-at-asrm-2024-conference/

For media attending the 2024 ASRM Scientific Congress who would like to connect on-site with Prelude physicians to further discuss their abstracts, or for media interested in reporting on any one of these studies, please contact Mia Humphreys at [email protected].

About Inception Fertility™

Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes.

Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) – including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services – and they continue to lead the industry by building on these technologies by through development, research and thought leadership.

Through its growing family of national organizations – which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception – Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.

About The Prelude Network®

The Prelude Network® (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility™ – a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility.

Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others.

Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility McAllen (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida).